Clinical Trial

TAMBE Japan Post-Marketing Surveillance

Name: TAMBE Japan Post-Marketing Surveillance — clinical trial record (NCT07147569)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.

Protocol Amendment History 1 change

notable Trial sites expanded: 1 -> 5 locations 2026-05-06

Trial Details

NCT Number	NCT07147569
Lead Sponsor	W.L.Gore & Associates Collaborators: CMIC Co, Ltd. Japan
Conditions	Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm
Enrollment	100 participants
Start Date	2026-03-27
Primary Completion	2034-02-28 (estimated)
Study Completion	2034-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-05-05